Sanofi
SNY
$47.13
-$0.30-0.63%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 38.50B | 39.29B | |
| Total Other Revenue | -- | -- | 3.71B | 3.61B | |
| Total Revenue | -- | -- | 42.21B | 42.89B | |
| Cost of Revenue | -- | -- | 13.09B | 13.45B | |
| Gross Profit | -- | -- | 29.12B | 29.44B | |
| SG&A Expenses | -- | -- | 8.73B | 9.19B | |
| Depreciation & Amortization | -- | -- | 1.90B | 2.05B | |
| Other Operating Expenses | -- | -- | 4.08B | 4.17B | |
| Total Operating Expenses | -- | -- | 34.92B | 35.99B | |
| Operating Income | -- | -- | 7.30B | 6.91B | |
| Income Before Tax | -- | -- | 4.65B | 5.08B | |
| Income Tax Expenses | -- | -- | 708.26M | 708.22M | |
| Earnings from Continuing Operations | -- | -- | 3.95K | 4.38K | |
| Earnings from Discontinued Operations | -- | -- | 217.42M | 170.44M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -28.76M | -37.63M | |
| Net Income | -- | -- | 4.50B | 4.87B | |
| EBIT | -- | -- | 7.30B | 6.91B | |
| EBITDA | -- | -- | 10.57B | 10.24B | |
| EPS Basic | -- | -- | 3.59 | 3.89 | |
| Normalized Basic EPS | -- | -- | -- | 0.78 | |
| EPS Diluted | -- | -- | 3.58 | 3.89 | |
| Normalized Diluted EPS | -- | -- | -- | 0.78 | |
| Average Basic Shares Outstanding | -- | -- | 5.00B | 5.00B | |
| Average Diluted Shares Outstanding | -- | -- | 5.01B | 5.01B | |
| Dividend Per Share | -- | -- | 4.05 | 4.05 | |
| Payout Ratio | -- | -- | -- | -- | |